loader
Please Wait
Applying Filters...

Market Place

Market Place

Market Place

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search
All
API
FDF
Price
Services
Excipients
Enquiries

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Price
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    FDA_Warning_Letters, Import_Alerts_&_EU_Non-Compliances_in_2019
    X

    Information, Expiry & Status of FDA Orange Book Patents covering 10183020

    Client EmailClient Virtual Booth
    Menu

    capsugel-m-2020-03-30

    chemwerth-inc-m-2020-03-30

    Filters Filter
    ×
    FILTER DATA :

    filter

    ASTRAZENECA PHARMS

    filter

    10183020

    filter

    Blank

    filter

    Y

    filter

    2035-01-02

    FILTER DATA FILTER DATA

    ASTRAZENECA PHARMS

    • FDA
    • EDQM

    Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    United Kingdom Flag United Kingdom

    Post An Enquiry Post An Enquiry

    Virtual Booth Virtual Booth

    OSIMERTINIB MESYLATE

    Contact the Supplier

    Supporting Information : Click here to upload a PDF

    10183020
    Y
    2035-01-02
    U-2289
    208065
    1

    ASTRAZENECA PHARMS

    • FDA
    • EDQM

    Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    United Kingdom Flag United Kingdom

    Post An Enquiry Post An Enquiry

    Virtual Booth Virtual Booth

    OSIMERTINIB MESYLATE

    Contact the Supplier

    Supporting Information : Click here to upload a PDF

    10183020
    Y
    2035-01-02
    U-2289
    208065
    2

    ASTRAZENECA PHARMS

    • FDA
    • EDQM

    Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    United Kingdom Flag United Kingdom

    Post An Enquiry Post An Enquiry

    Virtual Booth Virtual Booth

    OSIMERTINIB MESYLATE

    Contact the Supplier

    Supporting Information : Click here to upload a PDF

    10183020
    Y
    2035-01-02
    U-1777
    208065
    TREATMENT OF PATIENTS WITH METASTATIC EPIDERMAL GROWTH FACTORE RECEPTOR (EGFR) T790M MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC), WHO HAVE PR
    1

    ASTRAZENECA PHARMS

    • FDA
    • EDQM

    Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    United Kingdom Flag United Kingdom

    Post An Enquiry Post An Enquiry

    Virtual Booth Virtual Booth

    OSIMERTINIB MESYLATE

    Contact the Supplier

    Supporting Information : Click here to upload a PDF

    10183020
    Y
    2035-01-02
    U-1777
    208065
    TREATMENT OF PATIENTS WITH METASTATIC EPIDERMAL GROWTH FACTORE RECEPTOR (EGFR) T790M MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC), WHO HAVE PR
    2

    PharmaCompass >>

    First
    Previous
    Next
    Last
    Contact us
    to update this info

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search